科技广场Issue(3)：62-72,11.
基于知识产权全链条的生物医药企业创新能力评价研究
Research on the Evaluation of the Innovation Capability of Biopharmaceutical Enterprises Based on the Full Chain of Intellectual Property
摘要
Abstract
This paper examines five biopharmaceutical industries including ethnic drugs of unique tradi-tional Chinese medicine,chemical medicine,biotechnology drugs,medical devices,and marine bio-medicine as well as five secondary categories and 12 subdivided technical fields.Based on the full chain model of the creation,application,protection,and management of intellectual property,it builds an index system for evaluating the innovation capability of enterprises as a way to make a comprehen-sive assessment of the innovation capability of the intellectual property of biopharmaceutical enterpri-ses.The results indicate that the biopharmaceutical industry has good innovation capability of intellec-tual property as a whole,and the chemical pharmaceutical industry stands out in the comprehensive e-valuation of the innovation capability with a significant advantage;and biopharmaceutical enterprises have a strong creative ability of intellectual property in all subdivided fields,but with poor performance in the application of intellectual property.关键词
生物医药/知识产权/全链条/创新能力/评价体系Key words
Biomedicine/Intellectual Property/Full Chain/Innovation Capability/Evaluation System分类
生物科学引用本文复制引用
谭芳香,王海伶,侯圣君,周惠..基于知识产权全链条的生物医药企业创新能力评价研究[J].科技广场,2024,(3):62-72,11.基金项目
广西科技发展战略研究专项"RCEP国家科技创新发展指数分析及广西与RCEP国家重点产业专利技术转移合作研究"(项目编号:桂科ZL23014002) （项目编号:桂科ZL23014002）
广西知识产权项目"广西生物医药产业专利导航应用示范"(项目编号:桂知ZX2022026) （项目编号:桂知ZX2022026）
